ホーム › 胆管癌（胆管細胞癌） › テキサス
テキサスにおける胆管癌（胆管細胞癌）の臨床試験
テキサス内の拠点で、胆管癌（胆管細胞癌）に関する15件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
A Study of PHST001 in Advanced Solid Tumors
- START Center for Cancer Research - Texas, Fort Worth
- MD Anderson Cancer Center, Houston
- NEXT Oncology - Dallas, Irving
- 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/05更新 · NCT06840886A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- NEXT Austin, Austin
- START Center for Clinical Research, Fort Worth
- University of Texas MD Anderson Cancer Center, Houston
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06270706A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
- University of Texas Southwestern Medical Center (Site 104), Dallas
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07265674A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Texas Oncology - DFW (Sammons CC), Dallas
- Baylor College of Medicine, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213791A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Next Oncology - Austin, Austin
- Next Oncology - Houston, Houston
- Next Oncology - Dallas, Irving
- 他1件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07488676Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/08更新 · NCT05732831A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Baylor Scott & White Research Institute, Dallas
- University of Texas MD Anderson Cancer Center, Houston
- Baylor Scott & White Medical Center, Temple
被験者募集中第2相
8歳以上 · 全性別 · 2026/07/27更新 · NCT05503797Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
- University of Texas, MD Anderson Cancer Center, Houston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/13更新 · NCT05874414A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
- NEXT Dallas, Dallas
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/07更新 · NCT07337525A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- MD Anderson Cancer Center, Houston
- Next Oncology-Oncology, San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/02更新 · NCT07169734A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- The University of Texas MD Anderson Cancer Center, Houston
- NEXT Oncology, San Antonio
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/29更新 · NCT07458347A Study of MGC028 in Participants With Advanced Solid Tumors
- South Texas Accelerated Research Therapeutics (START) San Antonio, San Antonio
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/27更新 · NCT06723236Molecular Epidemiology of Biliary Tree Cancers
- M D Anderson Cancer Center, Houston
被験者募集中観察研究
全年齢 · 全性別 · 2026/04/17更新 · NCT05179486A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
- M D Anderson Cancer Center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/16更新 · NCT05967182SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Dallas
- Massive Bio SYNERGY-AI site, Houston
- Massive Bio SYNERGY-AI site, Temple
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。